International Pricing Index Could Suffer From Industry Gaming
Former US FDA commissioner Scott Gottlieb doesn't "want to give too much away," but expresses skepticism about Trump administration's ability to implement its international price index proposal, noting there are ways for brand companies to game the system.
You may also be interested in...
Pelosi Rx Pricing Bill Offers Big Savings, Big Drop In Drug Development – CBO
Overall effect on health of US families stemming from increased use of drugs but decreased availability of new drugs is 'unclear,' the Congressional Budget Office concludes in its preliminary analysis of HR 3.
Florida’s Importation Plan: 45% Markup On Canadian Prices Expected To Cover Costs And Produce Savings
Plan will be limited to purchases by state agencies and organizations. Drugs considered eligible for importation include treatments for HIV, multiple sclerosis and epilepsy.
Gottlieb Tells Brand Firms To Sell Samples For Generics – Or Face The Consequences
The idea could help quiet growing criticism over system gaming and high drug prices.